TET1 and cancer: Indeed, the multiple cancer cell lines studied, including nasopharyngeal, esophageal, lung, gastric, colon, breast, cervical, and renal carcinomas, as well as lymphomas, showed high frequency TET1 promoter methylation and silencing [72].